M.Pharm. in Drug Regulatory Affairs 

at R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur

R. C. Patel Institute of Pharmaceutical Education and Research allows admission to M.Pharm. in Drug Regulatory Affairs course at the PG level. In terms of NIRF 2024 ranking, it is ranked at #56. Candidates seeking admission to M.Pharm. in Drug Regulatory Affairs course must pay a total tuition fee of INR 2,73,044 for the whole duration of the course. The total seats available for M.Pharm. in Drug Regulatory Affairs at R. C. Patel Institute of Pharmaceutical Education and Research for candidates of various categories are 15. Further, candidates can check out other courses of R. C. Patel Institute of Pharmaceutical Education and Research M.Pharma.

R. C. Patel Institute of Pharmaceutical Education and Research M.Pharm. in Drug Regulatory Affairs fee is inclusive of several components, such as tuition fee, hostel fee, examination fee, and more. The institute may charge an additional fee at its discretion. Some of these are to be paid only once during admission, while the remaining components can be paid annually. The total tuition fee for M.Pharm. in Drug Regulatory Affairs at the institute is INR 2,73,044. Check out the following table to know in detail about R. C. Patel Institute of Pharmaceutical Education and Research M.Pharm. in Drug Regulatory Affairs fee breakup:

The M.Pharm. in Drug Regulatory Affairs course provided at R. C. Patel Institute of Pharmaceutical Education and Research is been ranked #56 by NIRF in the year 2024. However, students must note that the M.Pharm. in Drug Regulatory Affairs course was not ranked individually by NIRF. However, the entire M.Pharma is ranked by NIRF. Hence, it can be said that this ranking reflects the performance of the entire M.Pharma and not just the M.Pharm. in Drug Regulatory Affairs course. Find out more information on the rankings received by R. C. Patel Institute of Pharmaceutical Education and Research for the M.Pharm. in Drug Regulatory Affairs below: